Axelle Lascaux

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

18 F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review.

18 F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review.

Journal: Frontiers in nuclear medicine

Published: November 03, 2021

Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.

Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.

Journal: Cancer medicine

Published: March 01, 2021

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant.

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant.

Journal: Cancers

Published: February 22, 2021

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.

Journal: Cancers

Published: August 05, 2020

Vinblastine for elderly and frail patients with Hodgkin lymphoma.

Vinblastine for elderly and frail patients with Hodgkin lymphoma.

Journal: Leukemia & lymphoma

Published: July 28, 2020

Choline PET/CT in Multiple Myeloma.

Choline PET/CT in Multiple Myeloma.

Journal: Cancers

Published: April 28, 2020

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.

Journal: Annals of hematology

Published: January 28, 2020

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Journal: Cancer medicine

Published: June 07, 2019

Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.

Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.

Journal: British journal of haematology

Published: March 19, 2019

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: October 23, 2014

ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?

ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?

Journal: American journal of hematology

Published: October 01, 2014

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis.

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis.

Journal: Haematologica

Published: May 20, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026